JILLIAN STAUFFER: Open Payments
NPI 1699075580 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,659 in 129 payments from 20 companies in 2025. Trend: 2023 $1,906 · 2024 $1,697 · 2025 $2,659
Food & beverage: $2,575Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $656 |
| Janssen Biotech, Inc. | 10 | $326 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $236 |
| GENZYME CORPORATION | 11 | $227 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $203 |
| PFIZER INC. | 10 | $152 |
| QOL Medical, LLC | 5 | $144 |
| Ardelyx, Inc. | 6 | $127 |
| Phathom Pharmaceuticals, Inc. | 6 | $99 |
| Madrigal Pharmaceuticals | 4 | $89 |
Products named: TREMFYA, DUPIXENT, RINVOQ, XIFAXAN, ENTYVIO, Sucraid, IBSRELA, MAVYRET.
Industry payments across PA — which companies pay providers there.
